Data as of Friday, October 23, 2026From 500 companies’ SEC filings · refreshed twice a day · Send feedback
Companies / Health Care / Health Care Technology

Solventum stock buybacks

SOLV
$355Mbought back in the 12 months to Jun 30, 2026

Solventum bought back $355M of its stock in the last twelve months, $188M more than it paid out in stock compensation. Its share count is down 1.1% from a year earlier.

Stock repurchases by quarter
$0$150M$300MQ1 '25Q2 '26
Show as table
PeriodValue
Q1 '25$0
Q2 '25$0
Q3 '25$0
Q4 '25$0
Q1 '26$67M
Q2 '26$288M
Diluted shares outstanding
173.4M174.6M175.7MQ1 '25Q2 '26
Show as table
PeriodValue
Q1 '25174.8M
Q2 '25175.2M
Q3 '25175.4M
Q4 '25175.8M
Q1 '26175.5M
Q2 '26173.3M
$288Mlast quarter (Q2 2026)
$188Mnet of stock compensation ($167M)
−1.1%diluted shares, 1 year
—diluted shares, 5 years
—dividends, 12 months
—of free cash flow (−$118M) spent on buybacks
$0raised by issuing stock, 12 months
170.2Mshares outstanding (Jul 31, 2026)

Questions

Does Solventum buy back its stock?
Solventum bought back $355M of its stock in the last twelve months, $188M more than it paid out in stock compensation. Its share count is down 1.1% from a year earlier.

Latest filing used: 10-Q for the period ending Jun 30, 2026, filed Aug 5, 2026 · open on SEC.gov

Other Health Care companies